Name: NBIX Income Statement - Neurocrine Biosciences Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

NBIX - Neurocrine Biosciences Inc.

USD | NASDAQ | Healthcare

NBIX Income Statement - Neurocrine Biosciences Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	814.5	805.5	794.9	687.5	572.6	627.7	622.1	590.2	515.3	515.2	498.8	452.7	420.4	412.0	387.9	378.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	3,102.4	2,860.5	2,355.3	1,887.1	1,488.7	1,133.5	1,045.9	788.1	451.2	161.6	15.0	19.8	0.0	2.9	53.1	77.4	33.5	3.0
Cost of Revenue	56.7	52.1	34.0	39.7	23.2	14.3	10.1	-	4.9	1.3	0.0	0.0	-	-	-	-	-	-
Gross Profit	3,045.7	2,808.4	2,321.3	1,847.4	1,465.5	1,119.2	1,035.8	-	446.3	160.4	15.0	19.8	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	160.5	121.8	94.3	81.5	46.4	39.2	37.2
Operating Income
Operating Income	788.9	619.1	570.5	250.9	249.0	102.5	163.0	72.3	36.8	(131.4)	(147.4)	(94.2)	(64.4)	(49.7)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	2.8	1.9	0.6	0.4	0.5	0.4
Tax & Net
Income Tax Expense	268.9	226.8	144.7	82.4	59.4	11.8	(300.6)	9.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0
Per Share
EPS Basic	6.65	4.81	3.40	2.56	1.61	0.95	4.38	0.40	0.23	(1.62)	(1.63)	(1.05)	(0.81)	(0.69)	0.08	0.68
Supplementary Data
EBITDA	-	645.1	594.0	268.7	264.1	113.4	171.6	79.7	40.8	(129.0)	(145.9)	(93.2)	(63.6)	(49.0)	2.1	34.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	73.2	-	-	-	58.3	-	-	61.7	37.7	39.1	35.5	37.0	48.9	25.6	22.5	21.9	51.9	22.6	20.9	26.9
Selling General & Administrative	318.5	301.8	291.6	286.3	276.5	287.8	234.3	242.0	243.1	218.9	204.2	221.8	242.7	182.9	186.3	182.8
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	7.2	-	-	-	6.6	-	-	-	5.3	-	-	-	4.1	-	-	-
Amortization of Intangibles	0.1	-	-	-	1.0	-	-	-	0.9	-	-	-	0.9	-	-	-	0.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	621.1	594.6	555.9	541.9	549.0	485.7	438.3	444.8	416.0	364.9	357.6	379.1	534.6	308.6	300.1	323.5

Operating Income
Operating Income	193.4	210.9	239.0	145.6	23.6	142.0	183.8	145.4	99.3	150.3	141.2	73.6	(114.2)	103.4	87.8	54.7	3.1	(36.3)	44.5	62.8	31.5	71.8	(44.3)	76.6	58.9	48.8	90.1	34.4	(101.0)	21.8	54.3	(1.9)	(37.4)	11.8	(6.0)	(57.3)	(79.9)	(46.3)	(38.4)	(41.8)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	1.1	1.1	1.1	1.3	1.1	1.1	1.2	2.2	2.6	6.6
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	53.4	28.5	52.8	13.9	(8.9)	20.6	6.5	(46.8)	(64.8)	47.9	(25.6)	48.0	10.9	14.5	10.1	(78.0)	18.3
Pre-Tax Income	246.8	239.4	291.8	159.5	14.7	162.6	190.3	98.6	34.5	198.2	115.6	121.6	(103.3)	117.9	97.9	(23.3)

Tax & Net
Income Tax Expense	48.9	85.7	82.3	52.0	6.8	59.5	60.5	33.6	(8.9)	50.5	32.5	26.1	(26.7)	28.9	29.4	(6.4)	7.5	(6.5)	8.0	15.2	(4.9)	(306.2)	0.5	3.6	1.5	4.6	4.6	0.8	(0.5)	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	197.9	153.7	209.5	107.5	7.9	103.1	129.8	65.0	43.4	147.7	83.1	95.5	(76.6)	89.0	68.5	(16.9)	13.9
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	197.9	153.7	209.5	107.5	7.9	103.1	129.8	65.0	43.4	147.7	83.1	95.5	(76.6)	89.0	68.5	(16.9)	13.9
Net Income Attributable To Parent	197.9	153.7	209.5	107.5	7.9	103.1	129.8	65.0	43.4	147.7	83.1	95.5	(76.6)	89.0	68.5	(16.9)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	197.9	153.7	209.5	107.5	7.9	103.1	129.8	65.0	43.4	147.7	83.1	95.5	(76.6)	89.0	68.5

Per Share
EPS Basic	1.97	-	2.11	1.09	0.08	-	1.28	0.64	0.43	-	0.85	0.98	(0.79)	-	0.72	(0.18)	0.15	-	0.24	0.45	0.34	-	(0.62)	0.86	0.40	-	0.59	0.56	(1.12)	-	0.56	(0.07)	-	-	(0.13)	-	-	-	-	-
EPS Diluted	1.91	-	2.04	1.06	0.08	-	1.24	0.63	0.42	-	0.82	0.95	(0.79)	-	0.69	(0.18)	0.14	-
Shares Basic	100.5	-	99.4	99.0	99.7	-	101.1	100.8	99.8	-	97.9	97.6	97.1	-	95.8	95.6	95.3	-
Shares Diluted	103.4	-	102.5	101.0	102.5	-	104.3	103.9	103.6	-	101.1	100.2	97.1	-	99.0	95.6	97.6	-

Supplementary Data
EBITDA	200.6	-	-	-	30.2	-	-	-	104.6	-	-	-	(110.1)	-	-	-	6.4	-	-	-	34.0	-	-	-	61.0	-	-	-	(99.4)	-	-	-	(36.7)	-	-	-	(79.4)	-	-	-
EBIT	193.4	210.9	239.0	145.6	23.6	142.0	183.8	145.4	99.3	150.3	141.2	73.6	(114.2)	103.4	87.8	54.7	3.1	(36.3)	44.5